Bruton tyrosine kinase (Btk) suppresses osteoblastic differentiation.

about

Bruton tyrosine kinase (Btk) suppresses osteoblastic differentiation.

Item

http://www.wikidata.org/entity/Q38955617

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Bruton tyrosine kinase (Btk) suppresses osteoblastic differentiation.

@en

type

Item

label

Bruton tyrosine kinase (Btk) suppresses osteoblastic differentiation.

@en

prefLabel

Bruton tyrosine kinase (Btk) suppresses osteoblastic differentiation.

@en

P1476

Bruton tyrosine kinase (Btk) suppresses osteoblastic differentiation.

@en

P2093

Chikahisa Higuchi

http://www.w3.org/2001/XMLSchema#string

Dai Otsuki

http://www.w3.org/2001/XMLSchema#string

Hideki Yoshikawa

http://www.w3.org/2001/XMLSchema#string

Kenrin Shi

http://www.w3.org/2001/XMLSchema#string

Kiyoshi Yoshida

http://www.w3.org/2001/XMLSchema#string

Kosuke Ebina

http://www.w3.org/2001/XMLSchema#string

Shoichi Kaneshiro

http://www.w3.org/2001/XMLSchema#string

P2860

The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells

The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy

Signaling network of the Btk family kinases.

Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia.

Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765.

The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases.

Molecular targeted approaches in mantle cell lymphoma.

The tec family tyrosine kinase Btk Regulates RANKL-induced osteoclast maturation.

P2888

s00774-014-0612-8

P304

486-495

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00774-014-0612-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265791651

http://www.w3.org/2001/XMLSchema#string

P698

25230818

http://www.w3.org/2001/XMLSchema#string